Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant paclitaxel followed by doxorubicin and cyclophosphamide on breast conservation rates: Surgical results from CALGB 40603 (Alliance).
- Citation:
- Meeting Instance:
- ASA 2015
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2427
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Mehra Golshan Constance T. Cirrincione Donald A. Berry William M. Sikov Sara Jasinski Tracey F. Weisberg George Somlo Eric P. Winer Clifford Hudis David W. Ollila
- Networks:
- CA043, LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NY016, RI005
- Study
- CALGB-40603
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: